Brecksville, OH – January 28, 2026 – Auxano® Medical, an innovator in orthopedic implant technology, today announced the launch of ARKEO™, a next-generation wedge fixation system designed to deliver enhanced control, reproducibility, and biologic integration in foot and ankle corrective procedures.
Auxano® Medical Launches ARKEO™ Wedge Fixation System, Advancing Precision in Foot & Ankle Osteotomies
1 min read Premium comments
OTWPRARKEOAuxano Medicalfoot and ankle corrective procedures
ARKEO™ was engineered with a focus on anatomical fit and surgical precision, pairing Auxano® Medical’s proprietary surface technology with an open, biologically favorable design. The system is intended to provide surgeons with reliable fixation while supporting optimal graft incorporation at the osteotomy site.
“ARKEO™ represents our commitment to solving real surgical challenges with thoughtfully engineered solutions,” said Joe Harr, Sales and Distribution Manager of Auxano® Medical. “From implant architecture to instrumentation, every element of ARKEO™ was designed to help surgeons achieve consistent, confident outcomes.”
Key Features of the ARKEO™ System Include:
- Anatomical, Subflush Design – Designed to sit subflush to the bone to help minimize soft tissue irritation
- Enhanced Fixation – Pillared surface morphology intended to support initial stability and long-term fixation
- Open Architecture – Large central graft window and thru-growth fenestrations maximize graft packing and promote biologic fixation
- Intuitive Instrumentation – A comprehensive surgical set designed to improve reproducibility and surgeon control
The ARKEO™ system includes dedicated instrumentation such as a Hintermann distractor, trials, inserter, impactor, and accessory implants, all provided non-sterile in a steam-sterilizable tray. The system is indicated for use in Evans and Cotton osteotomies with ancillary plating fixation.
ARKEO™ has received FDA 510(k) clearance for use in internal fixation of bone fractures and osteotomies of the foot and ankle.
About Auxano® Medical
Auxano® Medical develops and manufactures advanced orthopedic and surgical solutions that support improved patient outcomes and procedural efficiency. With a commitment to quality, innovation, and clinical collaboration, Auxano® delivers technologies that meet the highest standards of performance and reliability.
For more information, visit www.auxanomedical.net.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.